Enhancing emerging technology discovery in nanomedicine by integrating innovative sentences using BERT and NLDA
, et
19 nov. 2024
À propos de cet article
Catégorie d'article: Research Papers
Publié en ligne: 19 nov. 2024
Pages: 155 - 195
Reçu: 16 juin 2024
Accepté: 16 oct. 2024
DOI: https://doi.org/10.2478/jdis-2024-0031
Mots clés
© 2024 Yifan Wang et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Figure 1.

Figure 2.

Figure 3.

Figure 4.

Regional distribution of innovation indicators_
Region | Average count | Percentage (%) |
---|---|---|
USA | 91.0 | 0.35 |
Australia | 89.5 | 0.40 |
Poland | 87.5 | 0.33 |
France | 86.5 | 0.44 |
Greece | 85.5 | 0.42 |
Iraq | 83.5 | 0.42 |
Denmark | 83.0 | 0.38 |
Jordan | 82.0 | 0.35 |
Kenya | 81.0 | 0.34 |
Hungary | 81.0 | 0.38 |
Malaysia | 79.0 | 0.38 |
India | 75.5 | 0.39 |
Mexico | 75.5 | 0.47 |
Thailand | 75.5 | 0.25 |
China | 74.5 | 0.40 |
Germany | 74.0 | 0.41 |
Nepal | 73.5 | 0.44 |
Brazil | 73.0 | 0.40 |
Italy | 71.0 | 0.37 |
Netherlands | 71.0 | 0.45 |
Criteria for distinguishing sentences_
Sentences with academic innovation | Sentences that lack innovation |
---|---|
Introduce new ideas, unique approaches, or novel methods. | Furnish common background information or definitions. |
Display original discoveries, experimental results, or undocumented data. | Elucidate routine procedures and methods that are commonly used in this field. |
Propose unique applications, materials, or techniques. | Provide a summary of well-established information or results available in the literature. |
BERT model hyperparameterization_
Hyperparameter | Values | Description |
---|---|---|
batch_size | 32 | Number of samples per batch during training |
max_seq_length | 500 | Maximum length of input sequences |
learning_rate | 2e-5 | Learning rate, subject to tuning |
train_epochs | 20 | Number of training epochs |
warmup_proportion | 0.1 | Proportion of total training steps for learning rate warm-up |
adam_epsilon | 1e-8 | Epsilon value for the Adam optimizer |
dropout_prob | 0.1 | Dropout probability in dropout layers |
NLDA Topic-Word Distribution_
Topic 1: Nanostructures and Polymer Chemistry | Topic 2: Graphene and Nanocomposites in Drug Delivery | Topic 3: Nanomaterial Quality and Surface Properties | Topic 4: Nanoparticles in Cancer Research and Therapy | ||||
---|---|---|---|---|---|---|---|
Polymers | Structures | Bacteria | Diffraction | Nanoparticles | Solution | Nanoparticles | Treatment |
Nanoparticles | Nanostructures | Graphene | Surface | Nanomedicines | Surface | Transfection | Delivery |
Copolymer | Solution | Nanoparticles | Solution | Information | Factors | Migration | Concentration |
Treatment | Polymerization | Spectroscopy | Treatment | Product | Quality | Solution | Exosomes |
Surface | Polymerization | Nanocomposites | Coating | Treatment | Molecules | Pathway | Surface |
Microscope | Centrifugation | Survival | Metastasis | Nanoparticles | Solubility | Cancer | Treatment |
Supernatant | Reagent | Resistance | Cancer | Curcumin | Solution | Nanoparticles | Conversion |
Nanoparticles | Solution | Chemotherapy | Treatments | Encapsulation | Content | Nanosheets | Photothermal |
Minutes | Transmission | Antitumor | Cancers | Hydrogel | Surface | Solution | Hypoxia |
Microplate | Concentration | Nanoparticles | Doxorubicin | Storage | Treatment | Species | Performance |
Extract | Insulin | Animals | Staining | Adsorption | Solution | Inflammation | Solution |
Nanoparticles | Surface | Biodistribution | Committee | Nanoparticles | Treatment | Nanoparticles | Treatment |
Dendrimers | Delivery | Nanoparticles | Liver | Surface | Complexes | Macrophage | Responses |
Activities | Treatment | Sections | Solution | Nanotubes | Structures | Collagen | Surface |
Solution | Concentration | Group | Surface | Results | Material | Cytokines | Inflammatory |
Emerging technologies in nanomedicine_
Topic id | Topic meaning |
---|---|
12 | Inflammation and Biomaterial Interactions in Disease Research |
8 | Photothermal Therapy and Nanomaterials in Cancer |
6 | Antitumor Therapy and Tumor Stem Cells |
4 | Nanoparticles in Cancer Research and Therapy |
2 | Graphene and Nanocomposites in Drug Delivery |
16 | Animal Studies and Biomedical Protocols |
9 | Antidiabetic Nanodrug Carriers and Biomedical Applications |
7 | Nanoparticles and Drug Delivery |
NLDA Topic -Word Distribution_
Topic 13: Nanotechnology in Vaccine Research and Infectious Diseases | Topic 14: Liposomes and Receptors in Drug Delivery | Topic 15: Nanoparticles in Materials Science | Topic 16: Nanocarriers for Hormone Release and Antitumor Drugs | ||||
---|---|---|---|---|---|---|---|
Nanoparticles | Treatment | Peptides | Affinity | Nanoparticles | Silicon | Nanocarriers | Loading |
Authors | Concentration | Antibodies | Solution | Channel | Treatment | Nanoparticles | Micelle |
Science | Diseases | Vesicles | Receptor | Solution | Diffusion | Carrier | Circulation |
Solution | Results | Nanoparticles | Membranes | Surface | Results | Dialysis | Prodrug |
Nanotechnology | Disease | Conjugation | Treatment | Parameters | Frequency | Antitumor | Solution |
Emission | Wavelength | Internalization | Pathway | Dispersion | Product | Transport | Circulation |
Nanoparticles | Spectrum | Endocytosis | Nucleus | Nanoparticles | Solution | Nanoparticles | Solution |
Excitation | Signals | Nanoparticles | Surface | Centrifugation | Calibration | Penetration | Spheroids |
Resonance | Solution | Mechanisms | Treatment | Ethanol | Treatment | Vessels | Surface |
Resolution | Fluorescent | Solution | Pathways | Compound | Surface | Permeability | Treatment |
NLDA model hyperparameterization_
Hyperparameter | Values | Description |
---|---|---|
num_topicsint | 20 | Number of topics |
Alphaint | 50 | Alpha parameter of TND |
Betafloat | 0.01 | Beta parameter of TND |
Iterationsint | 200 | Number of training iterations |
random_seed | 54 | Random seed to ensure consistent results |
Model evaluation indicators_
Model | Accuracy | Precision | Recall | F1 |
---|---|---|---|---|
BERT+ Classifier | 0.836 | 0.864 | 0.853 | 0.858 |
TF-IDF+SVM | 0.524 | 0.537 | 0.530 | 0.533 |
TF-IDF+KNN | 0.600 | 0.617 | 0.593 | 0.604 |
TF-IDF+NB | 0.582 | 0.553 | 0.569 | 0.560 |
Word2Vec+ SVM | 0.650 | 0.658 | 0.614 | 0.635 |
Word2Vec+ KNN | 0.696 | 0.628 | 0.603 | 0.615 |
Word2Vec+ NB | 0.623 | 0.609 | 0.634 | 0.621 |
LDA Topic -Word Distribution_
Topic 1 | Topic 2 | Topic 3 | Topic 4 | Topic 5 | Topic 6 |
---|---|---|---|---|---|
protein | delivery | nanoparticles | nps | antibacterial | applications |
corona | cell | silver | nanoparticles | cells | properties |
cell | nanoparticles | agnps | delivery | bacteria | review |
proteins | review | activity | brain | activity | materials |
bone | drugs | nm | size | vivo | titanium |
exosomes | based | tumor | wound | clinical | nanosheets |
cells | high | cancer | materials | cancer | surface |
tumour | cell | therapy | tissue | therapy | go |
nanoparticles | clinical | cells | healing | photothermal | mxenes |
drug | detection | pdt | bone | agents | applications |
Results of the calculation of thematic indicators_
Innovation | Originality | Growth | Significance | Topic strength | Emerging degree | |
---|---|---|---|---|---|---|
Topic 12 | 0.793 | 0.446 | 0.390 | 0.913 | 1.000 | 0.722 |
Topic 8 | 1.000 | 0.489 | 0.698 | 0.507 | 0.567 | 0.614 |
Topic 6 | 0.632 | 0.591 | 0.616 | 0.709 | 0.375 | 0.595 |
Topic 4 | 0.580 | 0.296 | 1.000 | 0.592 | 0.499 | 0.569 |
Topic 2 | 0.145 | 0.566 | 0.191 | 0.730 | 0.777 | 0.533 |
Topic 16 | 0.557 | 0.769 | 0.581 | 0.359 | 0.426 | 0.529 |
Topic 9 | 0.351 | 0.342 | 0.144 | 0.882 | 0.376 | 0.474 |
Topic 7 | 0.530 | 0.315 | 0.391 | 0.709 | 0.284 | 0.465 |
Topic 3 | 0.272 | 0.000 | 0.342 | 1.000 | 0.256 | 0.427 |
Topic 5 | 0.403 | 1.000 | 0.426 | 0.103 | 0.180 | 0.417 |
Topic 13 | 0.310 | 0.217 | 0.379 | 0.768 | 0.046 | 0.383 |
Topic 15 | 0.000 | 0.124 | 0.000 | 0.777 | 0.609 | 0.363 |
Topic 11 | 0.090 | 0.213 | 0.360 | 0.753 | 0.044 | 0.343 |
Topic 14 | 0.292 | 0.238 | 0.222 | 0.684 | 0.071 | 0.341 |
Topic 1 | 0.264 | 0.263 | 0.262 | 0.506 | 0.268 | 0.334 |
Topic 18 | 0.208 | 0.479 | 0.238 | 0.540 | 0.000 | 0.333 |
Topic 10 | 0.329 | 0.758 | 0.404 | 0.000 | 0.246 | 0.330 |
Topic 20 | 0.358 | 0.089 | 0.206 | 0.705 | 0.117 | 0.328 |
Topic 17 | 0.216 | 0.332 | 0.447 | 0.392 | 0.156 | 0.318 |
Topic 19 | 0.273 | 0.544 | 0.255 | 0.127 | 0.007 | 0.242 |
Emerging nanomedicine technology keywords classification_
Category | Keywords |
---|---|
Nanomaterial Applications | Nanoparticles; Nanotubes; Nanofibers; Nanocrystals; Nanoshells; Metal nanoparticles (e.g.; Gold; Silver); Carbon nanomaterials (e.g.; Graphene; Fullerenes); Quantum dots; Polymeric nanoparticles; Nucleic acid Nanostructures |
Drug Delivery Systems | Drug-loaded nanoparticles; Nanomicelles; Nanoemulsions; Nanocapsules; liposomes; Polymeric drug conjugates; Targeted drug delivery; Controlled release systems; PH-responsive nanocarriers; Temperature-responsive nanocarriers |
Diagnostics and Imaging | Molecular imaging; Magnetic resonance imaging (MRI); Positron emission tomography (PET); Single photon emission computed tomography (SPECT); Optical imaging; Fluorescence imaging; Raman spectroscopy imaging; Upconversion nanoparticle imaging; Multimodal imaging |
Cancer diagnosis and treatment | Nanoparticles; Hypoxia therapy; Tumor-targeted therapy; Nanoimmunomodulators |
Nanotherapy for infectious diseases | Nano-antimicrobials; Inflammation; Antimicrobial peptides; Nano-vaccines; Nano-antibiotics |
Rational Design of Antimicrobial Peptides | Antimicrobial peptides (AMPs); Peptide design; Membrane disruption mechanisms; Antibiotic resistance |